Clinical Trial

Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated February 11, 2026 (before its estimated March 7, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics of a single dose administration of 'AD-115A' or 'AD-1151' in healthy adults.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-27.
Trial Details
NCT Number NCT07385235
Lead Sponsor Addpharma Inc.
Conditions Gastric Ulcer
Enrollment 46 participants
Start Date 2026-01-27
Primary Completion 2026-03-07 (estimated)
Study Completion 2026-03-16 (estimated)
Updated on ClinicalTrials.gov 2026-02-11